Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

Santen gains rights to TRACON's entoglin antibodies for eye uses

05.03.2014 / Scripintelligence

The Japanese eye care company will pay $10m up front to the private US venture plus undisclosed development and commercialization milestones and tiered royalties on global sales of TRC105, the lead project in the group. It will also cover all development…

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: